European Commission Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) for Patients With Certain Types of Endometrial Carcinoma
First Combination of Immunotherapy With Tyrosine Kinase Inhibitor Approved in Europe for Adult Patients With…
First Combination of Immunotherapy With Tyrosine Kinase Inhibitor Approved in Europe for Adult Patients With…
Approval Based on Results From CLEAR/KEYNOTE-581 Trial Demonstrating KEYTRUDA Plus LENVIMA Significantly Reduced the Risk…
CASA GRANDE, Ariz. & TORONTO--(BUSINESS WIRE)--$ASCU #ESG--Arizona Sonoran Copper Company Inc. (TSX:ASCU) (“ASCU” or the…
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Soft Tissue Repair Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.…
DUBLIN--(BUSINESS WIRE)--The "Construction in Malaysia - Key Trends and Opportunities to 2025 (Q4 2021)" report…
DUBLIN--(BUSINESS WIRE)--The "Australia Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook)…
Unveils a new Execution Management Initiative in India, the World’s Process Epicenter BANGALORE, India--(BUSINESS WIRE)--Celonis,…
Online-and-physical fair spotlights lifestyle products Helps businesses capture new opportunities HONG KONG--(BUSINESS WIRE)--With global sourcing…
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a study published in Clinical…
Dialpad India marks its three-year anniversary, has nearly doubled in size during the calendar year,…